Survey of HLA Distribution in Patients with End Stage Renal Disease Secondary to Reflux Nephropathy
PDF

Original Investigation

Survey of HLA Distribution in Patients with End Stage Renal Disease Secondary to Reflux Nephropathy

Istanbul Med J 2018;19(3):255-257 DOI: 10.5152/imj.2018.32748
, , , , , ,
PDF
Permissions

Abstract

Introduction:

To evaluate the human leukocyte antigen (HLA) types of patients with vesicoureteral reflux (VUR) who underwent renal transplantation for end-stage renal disease (ESRD) to investigate for any significant association.

Methods:

This retrospective study comprised 26 patients (male, 15; female, 11) with ESRD secondary to VUR (ESRD/VUR group) who underwent renal transplantation, and 38 healthy donors (female, 24; male, 14) were randomized in the control group. The Single Specific Primer-Polymerase Chain Reaction (low resolution) method was performed for HLA typing. The statistical analyses included chi-square test and calculation of odds ratio (OR).

Results:

The median age was 25.2 years (R, 10-41) in the ESRD/VUR group and 43.9 (R, 20-76) in the control group. A statistically significant difference between HLA A and B types was not observed. The HLA DRB1*01 was significantly higher in the ESRD/VUR group than in the control group (p=0,024). The OR for the HLA DRB1*01 was 2.727. The risk of developing ESRD secondary to VUR was 2.727 times higher in the presence of the HLA DRB1*01.

Conclusion:

An association between HLA DRB1*01 and ESRD secondary to VUR was established. The HLA DRB1*01 antigen could be interpreted as a poor prognostic factor of reflux nephropathy. This finding should be supported by further studies.